determining transfection conditions

16
Imagination at work. MyBioApp Determining transfection conditions with Cytell™ Cell Imaging System & siGLO™ Transfection Indicators

Upload: ge-healthcare-life-sciences

Post on 07-Aug-2015

215 views

Category:

Science


0 download

TRANSCRIPT

Page 1: Determining transfection conditions

Imagination at work.

MyBioApp

Determining transfection conditions with Cytell™ Cell Imaging System & siGLO™ Transfection Indicators

Page 2: Determining transfection conditions

2

Project Background

To explore the use of Dharmacon™ reagents with cell imaging and analysis products.

In this initial test, a plate was set up to measure uptake of a fluorescent transfection control at different concentrations with increasing amounts of DharmaFECT™ 1 transfection reagent.

siGLO™ Red Transfection Indicator and siGLO Green Transfection Indicator

Novel FAM- and DY-547-labeled RISC-independent controls, modified to localize to the nucleus as a clear signal of transfection success.

Useful for determination of optimal transfection conditions for siRNA in mammalian cells.

DharmaFECT 1

All-purpose transfection reagent, demonstrating efficient, low-toxicity delivery to over 80% of validated cell types.

DharmaFECT 2, 3, 4 provide chemically distinct alternatives when DharmaFECT 1 is not optimal for a particular cell type or density.siGLO transfection | 3 February 2015

Page 3: Determining transfection conditions

3

Experiment

• A549 cells were plated 24h before transfection at 10,000 cells/well in medium containing Ham’s F-12, 2 mM L-Glutamine, 1.5 g/L Sodium Bicarbonate and 10% FBS.

• siGLO™ Transfection Indicacors and DharmaFECT™ 1 transfection reagent were mixed in serum-free medium (HyClone™), incubated for 20 min at room temperature, full growth medium added to the transfection mix and then added to the cells.

• Incubate for 24hr, fix, and stain with Hoechst 33342.• Image on Cytell™ Cell Imaging System using siGLO Red or

siGLO Green BioApp build with MyBioApp creator. Blue Channel – All Cells Orange or Green Channel for siGLO Transfection Indicator (nuclear

reference segmentation)

siGLO transfection | 3 February 2015

Page 4: Determining transfection conditions

4

Experiment Setup

siGLO transfection | 3 February 2015

siGLO™ Transfection Indicator DharmaFECT™ 1

Mixture incubated for 20min at 25ºC in Hyclone™ serum free media to allow formation of lipid/nucleic acid complexFull

GrowthMedium

Add to cells

10,000 cells grown for 24h

Treated cells grown for 24h

Page 5: Determining transfection conditions

5

Plate Map for siGLO™ Green and siGLO Red Transfection Indicator

nM

siG

LO R

NA

nM

siG

LO R

NA

siGLO transfection | 3 February 2015

µL/wellDharmaFECT™ 1

µL/wellDharmaFECT 1

Page 6: Determining transfection conditions

6

siGLO Red

Setting the threshold for siGLO™ BioApp

siGLO transfection | 3 February 2015

Positive Control

Positive Control

Threshold is set just ahead of the histogram peak of a strong positive sample

siGLO Green

Negative Control

Negative Control

Page 7: Determining transfection conditions

7

Results for siGLO™ Green BioAppnM

siG

LO R

NA

nM

siG

LO R

NA

DharmaFECT 1

Negative

Controls

Favorable Transfection Conditions

Increased transfection increases with both siGLO and DharmaFECT™ 1 concentration.

siGLO transfection | 3 February 2015

Page 8: Determining transfection conditions

8

Results for siGLO™ Green Transfection Indicator

siGLO transfection | 3 February 2015

Page 9: Determining transfection conditions

9

Results for siGLO™ Red BioAppnM

siG

LO R

NA

nM

siG

LO R

NA

DharmaFECT 1

Negative

Controls

Increased transfection increases with both siGLO and DharmaFECT™ 1 concentration.

siGLO transfection | 3 February 2015

Favorable transfection conditions

Page 10: Determining transfection conditions

10

Results for siGLO™ Red Transfection Indicator

siGLO transfection | 3 February 2015

Page 11: Determining transfection conditions

11

Consistent results for siGLO™ Green and siGLO Red Transfection Indicators

siGLO transfection | 3 February 2015

0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.450

20

40

60

80

100

120

Transfection EfficiencysiGLO Red

100nM50nM25nM12.5nM

DharmaFECT 1

% T

ransfe

cte

d

0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.450

20

40

60

80

100

120

Transfection EfficiencysiGLO Green

100nM50nM25nM12.5nM

DharmaFECT™ 1

% T

ransfe

cte

d

Page 12: Determining transfection conditions

12

Importance of transfection optimization

Identifying optimal cell densities, transfection reagents, and concentrations is essential for effective implementation of RNA interference (RNAi) in cell-based experiments. • Poor delivery = poor gene knockdown

Not all cell types are amenable to the same transfection conditions. • Optimization should be carried out in each new cell type to

maximize siRNA delivery and minimize toxicity.

 

siGLO™ Transfection Indicators are non RISC-engaging molecules that localize to the nucleus, providing a distinct visual indication of transfection success. • Available with either DY-547 (Red) or 6-FAM (Green).

siGLO transfection | 3 February 2015

http://dharmacon.gelifesciences.com/rnai-and-custom-rna-synthesis/rnai-controls/siglo-rnai-controls/

Page 13: Determining transfection conditions

13

Summary

• Cytell™ Cell Imaging System was able to image and analyze siGLO™ Green and siGLO Red Transfection Indicators

• The BioApps created provided easily readable output tables that enable a user to determine transfection conditions (DharmaFECT™ formulation, amount of DhamaFECT and cell density) that are suitable for subsequent siRNA experiments

• Cytell™ Cell Imaging System and siGLO Transfection Indicators enable easy optimization of conditions for efficient siRNA delivery into cells

siGLO transfection | 3 February 2015

Page 15: Determining transfection conditions

Cytell, Dharmacon, DharmaFECT, Hyclone and SiGLOare trademarks of GE Healthcare companies. GE, Imagination at work and GE Monogram are trademarks of General Electric Company

All goods and services are sold subject to the terms and conditions of sale of the company within GE Healthcare which supplies them. A copy of these terms and conditions is available on request. Contact your local GE Healthcare representative for the most current information.

© 2015 General Electric Company – All rights reserved.First published April 2015

GE Healthcare UK limited, a General Electric Company.

www.gelifesciences.com

GE Healthcare UK LimitedAmersham Place,Little Chalfont,HP7 9NAUK

Page 16: Determining transfection conditions